LTR Pharma (ASX:LTP) Total Liabilities: A$0.46 Mil (As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.56
View Full Analysis

What is LTR Pharma Total Liabilities?

LTR Pharma ASX:LTP -4.27% 15 Total Liabilities is A$0.46 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100.

LTR Pharma's Total Liabilities for the quarter that ended in Dec. 2025 was A$0.46 Mil.

LTR Pharma's quarterly Total Liabilities increased from Dec. 2024 (A$0.43 Mil) to Jun. 2025 (A$0.70 Mil) but then declined from Jun. 2025 (A$0.70 Mil) to Dec. 2025 (A$0.46 Mil).

LTR Pharma's annual Total Liabilities increased from Jun. 2023 (A$0.02 Mil) to Jun. 2024 (A$0.43 Mil) and increased from Jun. 2024 (A$0.43 Mil) to Jun. 2025 (A$0.70 Mil).

LTR Pharma Total Liabilities Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Total Liabilities Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Total Liabilities
0.46 0.48 0.02 0.43 0.70

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial 0.33 0.43 0.43 0.70 0.46
ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LTR Pharma's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.701+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.70

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=32.211-31.511
=0.70

LTR Pharma's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.458+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.46

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=27.323-26.865
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of A$0.46 Mil mean?
LTR Pharma (ASX:LTP) has a Total Liabilities of A$0.46 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for LTR Pharma and its competitors.
Is LTR Pharma's Total Liabilities too high?
LTR Pharma's current Total Liabilities is A$0.46 Mil. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Total Liabilities compare to VRTX and REGN?
LTR Pharma's Total Liabilities of A$0.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for LTR Pharma and its competitors. LTR Pharma's current Total Liabilities is A$0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Total Liabilities of A$0.46 Mil. The current Total Liabilities is A$0.46 Mil. LTR Pharma's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Total Liabilities is A$0.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.56
Price